BridgeBio Pharma, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
BBIO on Nasdaq
Location
3160 Porter Dr., Suite 250, Palo Alto, CA

Insiders trading volume in the past year

BridgeBio Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Viking Global Investors Lp 10%+ Owner $954M Jul 18, 2023
KKR Genetic Disorder L.P. 10%+ Owner $650M -$149M -18.7% Sep 13, 2024
Neil Kumar Chief Executive Officer, Director $163M -$1.29M -0.78% Nov 19, 2024
Charles J. Homcy Director $45.8M Jun 21, 2024
Frank Mccormick Director $34.4M -$4.21M -10.9% Jun 21, 2024
Thomas Trimarchi President and COO $8.97M Nov 16, 2024
Brian C. Stephenson Secretary, Treasurer & CFO $4.35M -$196K -4.31% Nov 19, 2024
Richard Scheller Director $2.42M Feb 16, 2023
Randal W. Scott Director $282K -$314K -52.7% Jun 21, 2024
Hannah Valantine Director $196K -$326K -62.4% Jun 21, 2024
Douglas A. Dachille Director Jun 21, 2024
L. Saunders Director Jun 22, 2022
Ali J. Satvat Director Jun 21, 2024
James C. Momtazee Director Jun 21, 2024
Eric Aguiar Director Jun 21, 2024
Fred Hassan Director Jun 21, 2024
Andrew Lo Director Jun 21, 2024
Ronald J. Daniels Director Jun 21, 2024
Jennifer Cook Director Jun 21, 2024
Andrea Ellis Director Jun 21, 2024

Recent Insider Transactions by Companies or Individuals for BridgeBio Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.